Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.

by Jing Wang, Ru Chen, Shaowen Tang, Xiaozhen Lv, Shanshan Wu, Yuan Zhang, Yinyin Xia, Pei Gao, Dehua Tu, Dafang Chen, Siyan Zhan
Published 2015-01-01

Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort.

by Shaowen Tang, Xiaozhen Lv, Yuan Zhang, Shanshan Wu, Zhirong Yang, Yinyin Xia, Dehua Tu, Peiyuan Deng, Yu Ma, Dafang Chen, Siyan Zhan
Published 2013-01-01

NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population

by Xiaozhen Lv, Shaowen Tang, Yinyin Xia, Yuan Zhang, Shanshan Wu, Zhirong Yang, Xiaoting Li, Dehua Tu, Yixin Chen, Peiyuan Deng, Yu Ma, Dafang Chen, Ru Chen, Siyan Zhan
Published 2012-09-01

Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.

by Xiaozhen Lv, Shaowen Tang, Yinyin Xia, Xiaomeng Wang, Yanli Yuan, Daiyu Hu, Feiying Liu, Shanshan Wu, Yuan Zhang, Zhirong Yang, Dehua Tu, Yixin Chen, Peiyuan Deng, Yu Ma, Ru Chen, Siyan Zhan
Published 2013-01-01

Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.

by Penghui Shang, Yinyin Xia, Feiying Liu, Xiaomeng Wang, Yanli Yuan, Daiyu Hu, Dehua Tu, Yixin Chen, Peiyuan Deng, Shiming Cheng, Lin Zhou, Yu Ma, Lizhen Zhu, Weiwei Gao, Hongyuan Wang, Dafang Chen, Li Yang, Pingping He, Shanshan Wu, Shaowen Tang, Xiaozhen Lv, Zheng Shu, Yuan Zhang, Zhirong Yang, Yan Chen, Na Li, Feng Sun, Feng Sun, Xiaoting Li, Yingjian He, Paul Garner, Siyan Zhan
Published 2011-01-01